Press

Lesaffre announces the completion of its take-over of NattoPharma, a Norwegian nutraceutical company specializing in research and marketing of vitamin K2. With this acquisition, Gnosis by Lesaffre, the business unit of Lesaffre dedicated to human care, is strengthening its presence…

Lesaffre announces the acquisition of ABM, Advanced Biological Marketing, a company specialising in the development of bionutrition products for field crops in the American Midwest. With this acquisition, Agrauxine by Lesaffre, the business unit of Lesaffre specialized in crop protection,…

As a global player in microorganisms and fermentation, Lesaffre is continuing to invest in research and development as part of its activities in favour of human and animal health. The company has invested in new equipment to continue developing its…

Lesaffre and Recombia Biosciences to Advance Innovative Gene Editing technology through a strategic partnership Recombia Biosciences aims to harness its proprietary genome editing technologies to accelerate the development of yeast for sustainable production of fermented ingredients. For the next few…

On 19th of September, at the end of its annual general meeting, Lesaffre’s Board of Directors elected Thibaut de Ladoucette as Chairman, to replace Lucien Lesaffre, Chairman of the Board of Directors since 2012 and having reached the statutory age…